Bill Detail

S. 2121

Congress: 119

Title

SUPPORT for Patients and Communities Reauthorization Act of 2025

Summary

SUPPORT for Patients and Communities Reauthorization Act of 2025 This bill reauthorizes and revises Department of Health and Human Services (HHS) programs that address substance use disorders, overdoses, and mental health. For example, the bill reauthorizes for FY2026-FY2030 grant and other programs relating to • addressing substance use disorders with respect to pregnant and postpartum women, • prevention and recovery from substance use disorders for youth, • housing for individuals in recovery from substance use disorders, • community organizations facilitating recovery from substance use disorders, • loan repayment for certain health care providers treating substance use disorders, • prevention of overdoses of controlled substances, • treatment of children experiencing psychological trauma, and • mental and behavioral health education and training for medical and allied health students. Also, the bill revises several programs, including by (1) expanding a program that supports resources for first responders to include the purchase of drugs or devices to treat non-opioid overdoses, (2) expanding a program that supports employment services for individuals in recovery so as to allow for the provision of related transportation services, and (3) temporarily authorizing a regional technical assistance center to assist the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support. Additionally, the bill establishes new requirements for HHS, including requirements relating to • protecting the National Suicide Prevention Lifeline program from cybersecurity threats, • establishing a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and • reviewing and potentially revising the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act.

Sponsor

Sen. Bill Cassidy [R-LA]

Status

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Status as of Nov 16, 2026, 9:35 PM · synced 14h ago

Introduced

2025-06-18

Data source mode: cache

Bill Engagement

Lobbyists on the case

2 orgs · 8 lobbyists · 3 filings mention S. 2121 (SUPPORT for Patients and Communities Reauthorization Act of 2025) in LDA disclosures.

These are cached disclosure mentions, not verified current representation or confirmed event attendance.

Top orgs filing
Lobbyists on this bill
+ 6 more in the full intelligence view

Limited preview · paid intelligence

Keep the intelligence current—not just this one record.

Unlock every organization and lobbyist filing on this bill, the complete event and issue map, private team positions, and recurring movement alerts across the portfolio.

Federal Intelligence is $2,500 one-time for three months, or $9,000 for twelve months prepaid, for one named user. Full tracked federal calendar, connected organization/bill/disclosure research, and a private workspace. Fixed terms; no automatic renewal. No demo or scope email is required for standard access.

Buy Federal Intelligence · $2,500 for 3 monthsRequest a Sample by EmailPrefer a walkthrough first?Already a customer? Sign inGet free intelligence alerts →

After verified successful payment, access is activated within one business day and a secure setup link is emailed. Your term starts at activation. These links do not charge you or unlock records. A free alert subscription does not grant full access.